大健康_CBinsights-2019年第二季度健康产业报告_70页_5mb

Global Healthcare Report Q2 2019 Summary

Core Content

The Global Healthcare Report Q2 2019 by CB Insights provides an overview of investment trends, industry highlights, and key developments in the healthcare sector. The report highlights the growth of digital health, the impact of emerging technologies, and the performance of specific sub-sectors like clinical trials, women's health, cannabis, and AI in healthcare.

Main Points

Investment Trends

• Global Healthcare Investment: The first half of 2019 saw a record high in healthcare investment, reaching $26.9B compared to $26.5B in H1'18.
• Digital Health Funding: Digital health funding increased by 23% in Q2'19 to $3.5B, marking the second consecutive quarter of growth.
• Regional Funding Decline: Funding to Asian-based companies dropped by 39% in Q2'19, while North America and Europe also experienced declines.
• US State Performance: Massachusetts overtook New York as the second-largest state for digital health deals, with 29 rounds in Q2'19. California remained the leader with 85 deals.
• Top Investors: First Round Capital and Jumpstart Foundry led in digital health rounds, with overlapping investments in companies like CureFit and SigTuple. Other notable investors included Chiratae Ventures, Civilization Ventures, and Perceptive Advisers.
• Digital Health Unicorns: There were 38 VC-backed digital health unicorns, collectively valued at $90.7B.

Industry Highlights

Clinical Trials

• Funding Decline: Clinical trials tech funding dipped below previous highs.
• Patient Recruitment: Startups focused on accelerating patient recruitment and enrollment, using platforms like Citruslabs and SubjectWell. Citruslabs raised $2.57M Series A, while SubjectWell raised $10M Series A.
• EHR Integration: Elligo Health Research used EHR-connected data to speed up clinical research for physicians and study sponsors.

Women's Health

• Strong Deals: Women's health deals continued to be strong, with notable funding rounds.
• Fertility Services: Kindbody and Modern Fertility offered accessible fertility services with tech integration. Modern Fertility raised $15M Series A.
• Maternal Care: Elvie and JioVio provided maternal care through smart devices and IoT solutions. Elvie raised $42M Series B, while JioVio raised $70K seed round.
• D2C Strategy: Ro's D2C telehealth brand, Rory, targeted menopause solutions with $85M Series B funding.

Cannabis

• Record Funding: Cannabis deals and dollars neared record levels in Q2'19.
• Hemp & CBD: Hemp and CBD startups captured 25% of cannabis deals in Q2'19, up from 15% in Q2'18.
• Legalization Impact: Illinois became the 11th state to legalize cannabis, with its market projected to grow 9 times by 2023.
• PAX Mega-Round: PAX raised $420M in a Series E round, with a valuation of $1.7B. It provides internet-connected vaporizers for cannabis tracking.

AI in Healthcare

• AI Funding High: AI in healthcare funding reached a high in Q2'19.
• Top Rounds: Tempus led with a $200M round, followed by BlackThorn Therapeutics with $76M. These startups focused on precision medicine and data analysis.

Key Information

• CB Insights is a tech market intelligence platform that analyzes data on venture capital, startups, patents, and more to identify emerging trends and opportunities.
• The report emphasizes the shift towards digital health and the role of technology in transforming healthcare delivery.
• Digital Therapeutics: These companies are gaining traction for managing chronic diseases, with specific focus on joint pain and respiratory disorders.
• Emerging Markets: Japan, South Korea, and Sweden are noted as emerging countries in digital health, showing increasing deal activity.
• Deal Count Growth: The deal count in digital health is on the rise, with 371 deals in Q2'19, up from 354 in Q1'19.
• Later-Stage Deals: Later-stage deals are increasing, indicating maturity and growth in the digital health space.

Appendix

• Most Active Investors: A list of the most active digital health investors in Q2'19.
• Methodology: Details on how data was collected and analyzed for the report, focusing on equity rounds to VC-backed healthcare companies.

This report serves as a comprehensive guide to the evolving landscape of global healthcare investments and innovations in 2019.